Isolation, speciation and antifungal susceptibility patterns of candida isolated from cases of chronic balanoposthitis

Authors

  • N. Lakshmi Department of Microbiology, Andhra Medical College, Visakhapatnam, Andhra Pradesh
  • N. V. Hemalatha Department of Microbiology, Andhra Medical College, Visakhapatnam, Andhra Pradesh
  • P. Bala Murali Krishna Department of Microbiology, Andhra Medical College, Visakhapatnam, Andhra Pradesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20161957

Keywords:

Chronic balanoposthitis, Diabetes mellitus, Candida parapsilosis, Antifungal susceptibility, Amphotercin B

Abstract

Background:Balanoposthitis is a common condition affecting 11% of male genitourinary clinic attendees and it can be a recurrent or persistent condition. Various predisposing factors like diabetes mellitus, sexual intercourse and usage of oral antibiotics can cause chronic balanoposthitis. The Objective of the study was to isolation and speciation of candida and their antifungal susceptibility patterns from the cases of chronic balanoposthitis.

Methods: The study group comprised of swabs collected from 62 male patients with chronic balanoposthitis attending sexually transmitted diseases (STD) outpatient department (OPD), King George Hospital (KGH), Visakhapatnam. Standard mycological tests for the candida isolation, speciation and antifungal susceptibility were done.

Results: Out of 62 samples, (85%) were culture positive for candida. The most common species isolated was C. parapsilosis (37.7%), followed by C. glabrata (28.3%), C. albicans (15.09%), C. dubliniensis (9.4%), C. krusei (7.5%) and C. tropicalis (1.88%). Most of the candida species showed sensitivity to amphotericin B, Nystatin, clotrimazole and ketoconazole. A relative resistance to fluconazole and itraconazole was observed.

Conclusions: Chronic balanoposthitis is the most common infection in men attending STD, OPD. In the present study, diabetes is main predisposing factor than sexual intercourse and candida non albicans predominated over C. albicans. Resistance of candida species to azoles is on rise. This establishes the importance of determination of antifungal susceptibility patterns to prevent the emergence of drug resistance, prior to initiation of therapy.

 

References

Birley HDL, Walker MM, Luzzi Ga. Clinical features and management of recurrent balanitis; association with recurrent washing. Genitourin Med. 1993;69:400-3.

Vohra S, Badlani G. Balanitis and and balanoposthitis. Urolclin North Am. 1992;19:143-7.

Manian Fa, Alford Rh. Nosocomial infectious balanitis in neutropenic patients. South Med J. 1987;80:909-11.

Waugh Ma, Evans Egv, Nayyarke, Fong R. Clotrimazole (castren) in the treatment of candidalbalanitis in men. Br J Venereal Dis. 1978;54:184-6.

Davidson F. Yeasts and circumcision in the male. Br J Venereal Dis. 1977;53:121-3.

Rodin P, Kolantor B. Carriage of yeasts on the penis. BMJ. 1976;1:1223-4.

Waugh Ma. Clinical presentation of clinical balanitis-its differential diagnosis and treatment. Chemotherapy. 1982;28(suppl 1):56-60.

Oates Jk. Sexually transmitted skin diseases. Br J Sex Med. 1976;3:8-10.

Mccartney M. Practical medical microbiology. 14th edition.1996.

Chander J. Text book of medical mycology. 3rd edition. Mehta publishers; 2009.

Wayne PA. Method for antifungal disk diffusion susceptibility testing of yeasts. CLSI m44-a. 2004;23(6).

Engman Mf. A peculiar fungus infection of the skin (soorpilze) arch dermatol syphilol. 1920;1:730.

Belazi M, Velegraki A, Fleva A, Gidarakou I, Papanaum L, Baka D, et al. Candidal overgrowth in diabetic patients: potential predisposing factors. Mycoses. 2005;48:192-6.

Lisboa C, Santos A, Dias C , Azevedo F , Pina – Vaz C , Rodrigues A. Candida balanitis: risk factors. J Eur Acad Dermatol Venereol. 2010:24(7):820-6. Verma Sb, Wollina U. Looking through the cracks of diabetic candidal balanoposthitis. Int J Gen Med. 2011;4:511-3.

Verma SB, Wollina U, Looking through the cracks of diabetic candidal balanoposthitis ; Int J Gen Med. 2011;4:511-3.

Dockertywg SC. Candidalbalano-posthitis: a study of diagnostic: methods. Genitourin med. 1995;71:107-9.

Shivaprakasha S, Radhakrishnan K, Karim P. Candida spp. Other than candida albicans: a major cause of fungaemia in a tertiary care hospital. Indian journal of medical microbiology. 2007;25(4):405-7.

Abdennader S, Casin I, Janier M, Morel P. Balanitis and balanoposthitis: a review. Genitourinary Med. 1996;72;453-4.

Vellerfornase C, Calabro A, Miglietta A, Tarantello M, Biasinutto C, Peserico A. Mild balanoposthitis. Genitourin Med. 1994;70:345-6.

Jithendra K, Madhavulu B, Mohan PR, Munilakshmi P, Avinash G. Candida speciation from vaginal candidiasis and its antifungal succeptabilitys. International Journal Of Current Medical And Applied Sciences. 2015;5(3):144-8.

Velvizhi G. Clinico-mycologicalprofile of vaginal candidiasis in a tertiary care hospital. Indian journal of applied research. 2014;4(2):2249-555.

Pahwa N, Kumar R, Nirkhiwale S, Bandi A. Species distribution and drug susceptibility of candida in clinical isolates from a tertiary care centre at Indore. Indian Journal of Medical Microbiology. 2014;32(1):44-8.

Downloads

Published

2017-01-03

How to Cite

Lakshmi, N., Hemalatha, N. V., & Krishna, P. B. M. (2017). Isolation, speciation and antifungal susceptibility patterns of candida isolated from cases of chronic balanoposthitis. International Journal of Research in Medical Sciences, 4(7), 2817–2821. https://doi.org/10.18203/2320-6012.ijrms20161957

Issue

Section

Original Research Articles